Umbilical cord blood-derived CD34+ stem cells for treatment of chronic ischemic stroke
This study aims to determine the safety and possible effectiveness of intercerebral transplantation of hematopoietic CD34+ stem cells obtained from umbilical cord blood (UC-HSCs) to treat stroke.
Read More
Product Information for
Umbilical cord blood-derived CD34+ stem cells for treatment of chronic ischemic stroke